AKT1 and Alzheimer disease: Ex-4 can significantly rescue memory deficits and neuropathological changes in APP/PS1 AD mice, and it can downregulate the activities of N-acetylglucosaminyltransferase III and bisecting N-acetyl-d-glucosamine through the Akt/GSK-3β/β-catenin signaling pathway [70].